GA-Hecate antiviral properties on HCV whole cycle represent a new antiviral class and open the door for the development of broad spectrum antivirals-Reference-Cited by-同舟云学术

GA-Hecate antiviral properties on HCV whole cycle represent a new antiviral class and open the door for the development of broad spectrum antivirals

Published:2018-09-25 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Batista Mariana Nogueira,Sanches Paulo Ricardo da Silva,Carneiro Bruno Moreira,Braga Ana Cláudia Silva,Campos Guilherme Rodrigues Fernandes,Cilli Eduardo Maffud,Rahal Paula

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-32176-w.pdf

Reference35 articles.

1. Fosgerau, K. & Hoffmann, T. Peptide therapeutics: current status and future directions. Drug discovery today 20, 122–128, https://doi.org/10.1016/j.drudis.2014.10.003 (2015).

2. Funke, S. A. & Willbold, D. Peptides for therapy and diagnosis of Alzheimer’s disease. Current pharmaceutical design 18, 755–767 (2012).

3. Castel, G., Chteoui, M., Heyd, B. & Tordo, N. Phage display of combinatorial peptide libraries: application to antiviral research. Molecules 16, 3499–3518, https://doi.org/10.3390/molecules16053499 (2011).

4. Liu, X. et al. Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A. Journal of virology 87, 1649–1657, https://doi.org/10.1128/JVI.02201-12 (2013).

5. Thakur, N., Qureshi, A. & Kumar, M. AVPpred: collection and prediction of highly effective antiviral peptides. Nucleic acids research 40, W199–204, https://doi.org/10.1093/nar/gks450 (2012).

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The GA-Hecate Peptide inhibits the ZIKV Replicative Cycle in Different Steps and can Inhibit the Flavivirus NS2B-NS3 Protease after Cell Infection;Protein & Peptide Letters;2024-07

2. The Synthetic Peptide GA-Hecate and Its Analogs Inhibit Multiple Steps of the Chikungunya Virus Infection Cycle In Vitro;Pharmaceuticals;2023-09-30

3. Development of New Leishmanicidal Compounds via Bioconjugation of Antimicrobial Peptides and Antileishmanial Guanidines;ACS Omega;2023-09-06

4. A review of the antiviral activity of cationic antimicrobial peptides;Peptides;2023-08

5. Antiviral Evaluation of New Synthetic Bioconjugates Based on GA-Hecate: A New Class of Antivirals Targeting Different Steps of Zika Virus Replication;Molecules;2023-06-21